Prostaglandin E2 prevents diclofenac-induced enhancement of histamine release and inflammation evoked byin vivo challenge with compound 48/80 in the hamster cheek pouch
- 15 Downloads
Based on observations obtained by the use of intravital microscopy, we report that prostaglandins, (PGs) can exert inhibitory effects on mast cell-dependent inflammation. Thus, the PG-synthesis inhibitors diclofenac and indomethacin potentiated extravasation of plasma evoked by challenge with the mast cell secretagogue compound 48/80. Although the plasma leakage induced by compound 48/80 was in large mediated by histamine, neither diclofenac nor indomethacin potentiated the plasma leakage caused by exogenous histamine. These findings indicated that endogenous PGs inhibited the mast cell-dependent reaction at the level of mediator release. This mode of action was confirmed, as diclofenac was found to enhance thein vivo release of histamine that ensued challenge with compound 48/80. Moreover, the enhancement of the response to compound 48/80 observed after diclofenac treatment was prevented by local administration of PGE2 (30 nM). This inhibition included both the histamine release and the plasma leakage. In addition, diclofenac enhanced the leukocyte emigration after compound 48/80 challenge, and PGE2 reversed also this effect, suggesting that endogenous PGs (e.g. PGE2) also inhibited the release of chemotactic, mediators.
KeywordsHistamine Prostaglandin Indomethacin PGE2 Histamine Release
Unable to display preview. Download preview PDF.
- J. Björk, G. Smedegård, E. Svensjö and K.-E. Arfors,The use of the hamster cheek pouch for intravital microscopy studies of microvascular events. Prog. Appl. Microcirc.6, 41–53 (1984).Google Scholar
- L.M. Lichtenstein and H.R. Bourne,Inhibition of allergic histamine release by histamine and other agents which stimulate adenyl cyclase. InBiochemistry of Acute Allergic Reactions (Ed. K.F. Austen and E.L. Becker) pp. 161–174, Blackwell, Oxford, 1971.Google Scholar
- J.L. Walker,The regulatory function of prostaglandins in the release of histamine and SRS-A from passively sensitized human lung tissue. InAdvances in the Biosciences, vol. 9. (Eds. S. Bergström and S. Bernhard) pp. 235–240, Pergamon Press, Vieweg 1973.Google Scholar
- T.H. Lee, E. Israel, J.M. Drazen, A.G. Leitch, J. Ravalese III, E.J. Corey, D.R. Robinson, R.A. Lewis and K.F. Austen,Enhancement of plasma levels of biologically active leukotriene B compounds during anaphylaxis in guinea pigs pretreated by indomethacin or by a fish oil-enriched diet. J. Immunol.136, 2575–2582 (1986).PubMedGoogle Scholar
- T. Okazaki, V.S. Ilea, N.A. Rosario, R.E. Reisman, C.E. Arbesman, J.B. Lee and E. Middleton Jr,Regulatory role of prostaglandin, E in allergic histamine release with observations on the responsiveness of basophil leukocytes and the effect of acetylsalicylic acid. J. Allergy Clin. Immunol.60, 360–366 (1977).PubMedGoogle Scholar
- S.H. Ferreira and J.R. Vane,Mode of action of antiinflammatory agents which are prostaglandin synthetase inhibitors. InAnti-Inflammatory Drugs (Eds J.R. Vane and S.H. Ferreira) pp. 348–398, Springer, Berlin 1979.Google Scholar
- P. Hedqvist, S.-E. Dahlén and U. Palmertz,Leukotriene dependent airway anaphylaxis in guinea pigs. Prostaglandins28, 605–608 (1984).Google Scholar